Skip to main content
Log in

Mechanisms of Food Effects of Structurally Related Antiarrhythmic Drugs, Disopyramide and Bidisomide in the Rat

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To determine whether the rat is a good animal model for the food effects observed with bidisomide but not with the structurally similar antiarrhythmic drug, disopyramide in man and to explore a reason for the differences in the food effects of these compounds.

Methods. The following effects on the absorption of bidisomide and/ or disopyramide were examined in the rat: Food effects, gastrointestinal transit time under fasting and nonfasting conditions, pH effects, hypertonic solution effect of NaCl and glucose, bile effects, permeability, inhibitory effects by Gly, Gly-Gly, Gly-Pro, glucose and mannitol and drug binding to food.

Results. Remarkable food effects were observed with bidisomide but not with disopyramide. There was no difference in the GI transit time with and without food. The pH effect with and without food was similar. Effect of salt concentrations on bidisomide and disopyramide was similar. There was no bile effect on absorption of both compounds. Binding of bidisomide and disopyramide to food was similarly low. The apparent permeability of bidisomide was much lower than disopyramide especially in the ileum and its absorption was more inhibited by Gly, Gly-Gly and Gly-Pro.

Conclusions. In the rat, as previously seen in humans, the food effect was observed with bidisomide but not with disopyramide. This difference was in part due to both lower intestinal permeability of bidisomide compared to disopyramide and greater inhibition of absorption by the amino acid, Gly and the dipeptides, Gly-Gly and Gly-Pro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. L. A. Vismara, D. T. Mason, and E. A. Amsterdam. Clin. Phamcol. Ther. 16:330–335 (1974).

    Google Scholar 

  2. C. S. Cook, P. R. Gwilt, K. Kowalski, S. Gupta, J. Oppermann, and A. Karim. Drug Metab. Dipos. 18:42–49 (1990).

    Google Scholar 

  3. A. Karim. Angiology. 26:85–98 (1975).

    Google Scholar 

  4. C. S. Cook, G. B. Ames, M. E. Smith, K. G. Kowalski, and A. Karim. Pharm. Res. 10:1675–1681 (1993).

    Google Scholar 

  5. C. S. Cook, S. J. McDonald, and A. Karim. Xenobiotica. 23:1299–1309 (1993).

    Google Scholar 

  6. A. Karim, A. Piergies, and P. Needleman. J. Clin. Pharmacol. 35:921 (1995).

    Google Scholar 

  7. A. Karim. J. Clin. Pharmacol. 35:921 (1995).

    Google Scholar 

  8. F-H. Hsu, T. Prueksaritanont, M. G. Lee, and W. L. Chiou. J. Pharmacokin. Biopharm. 15:369–386 (1987).

    Google Scholar 

  9. G. A. Digenis, E. P. Sanderfer, A. F. Par, R. Beihn, C. McClain, B. M. Scheinthal, I. Ghebre-Sellassie, U. Iyer, R. U. Nesbitt, and E. Randinitis. J. Clin. Pharmacol. 30:621–631 (1990).

    Google Scholar 

  10. P. G. Welling. J. Pharmacokin. Biopharm. 5:291–334 (1977).

    Google Scholar 

  11. M. Gibaldi. Annals Pharmacotherapy. 26:829–834 (1992).

    Google Scholar 

  12. P. G. Welling. Annu. Rev. Nutr. 16:383–415 (1996).

    Google Scholar 

  13. W. W. Stargel, and J. A. Thomas. Adv. Pharmacol. 35:1–26 (1996).

    Google Scholar 

  14. J. H. G. Jonkman. Clin. Pharmacokinet. 16:162–179 (1989).

    Google Scholar 

  15. A. J. Humberstone, C. J. Porter, and W. N. Charman. J. Pharm. Sci. 85:525–529 (1996).

    Google Scholar 

  16. G. Dongowski, R. Neubert, H. Haase, and B. Schnorrenberger. Inter. J. Pharmaceutics. 144:233–239 (1996).

    Google Scholar 

  17. H. A. Semple and F. Xia. Drug Metab. Dispos. 23:794–798 (1995).

    Google Scholar 

  18. T. Ogiso, M. Iwaki, T. Tanio, R. Kawafuchi, and S. Hata. Biol. Pharm. Bull. 17: 112–116 (1994).

    Google Scholar 

  19. J. B. Dressman, R. R. Berardi, L. C. Dermentzglou, T. L. Russell, S. P. Schmaltz, Z. L. Barnett, and K. M. Jarvenpaa. Phar. Res. 7:756–761 (1990).

    Google Scholar 

  20. E. B. Nelson, J. L. Pool, and A. A. Tayler. Am. J. Med. 81:13–18 (1986).

    Google Scholar 

  21. A.d. Watson, D. R. Emslie, I. C. Martin, and J. R. Egerton. J. Vet. Pharmacol. Ther. 9:140–149 (1986).

    Google Scholar 

  22. S. C. Scott. H. J. Loke, N. S. Pready, N. P. Buller, and R. J. Cregeen. Br. J. Clin. Pharmacol. 23:585–587 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chyung S. Cook.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, KH., Xu, GX., Schoenhard, G.L. et al. Mechanisms of Food Effects of Structurally Related Antiarrhythmic Drugs, Disopyramide and Bidisomide in the Rat. Pharm Res 14, 1030–1038 (1997). https://doi.org/10.1023/A:1012101311826

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012101311826

Navigation